The expression of MCM6 was found to be enhanced and its high level had a close relationship with unfavorable prognosis in colorectal cancer [38], breast cancer [39], AO [15], HCC [14], endometrioid adenocarcinoma [40], lung cancer [41], meningiomas [42], cervical cancer [43], Hodgkin's lymphoma [44], and Merkel cell carcinoma [45]. The gene discussed is MCM6; the disease is hepatocellular carcinoma.